Showing 71-80 of 108 results for "".
- Investigational Neurotoxin Achieves 6-Month Duration in Phase 3: Revancehttps://modernaesthetics.com/news/investigational-neurotoxin-achieves-6-month-duration-in-phase-3-revance/2472157/Revance Therapeutics’ next-generation neuromodulator DaxibotulinumtoxinA for Injection (RT002) delivered positive top-line results in alleviating moderate-to-severe glabellar lines in two pivotal SAKURA Phase 3 trials with duraction of effect up to 6 months. RT002 appeared generally safe an
- Sonrei Expands Offerings with Three New Sunscreenshttps://modernaesthetics.com/news/sonrei-expands-offerings-with-three-new-sunscreens/2473088/Sonrei has expanded its product line with three new offerings: Sonrei Clearly Zinq Tinted Mineral Gel Sunscreen SPF 45,
- FDA Reviews sPMA Application for Hyaluronic Acid Injectable to Improve Neck Appearancehttps://modernaesthetics.com/news/fda-reviews-spma-application-for-hyaluronic-acid-injectable-to-improve-neck-appearance/2475595/The U.S. Food and Drug Administration (FDA) has accepted for review a supplemental premarket approval (sPMA) application for SKINVIVE by JUVÉDERM® (Allergan Aesthetics, an AbbVie company), expanding its potential use to include treatment of horizontal neck lines in
- Evolus Expands Global Footprint with Introduction of Treatment in Australiahttps://modernaesthetics.com/news/evolus-expands-global-footprint-with-introduction-of-treatment-in-australia/2473641/The performance beauty company, Evolus, has begun operations in Australia with the launch of Nuceiva, a prabotulinumtoxinA. Nuceiva is approved by the Therapeutic Goods Administration (TGA) for the temporary improvement in the appearance of moderate to severe glabella lines in adul
- Carotenoid Supplement May Boost Skin Health and Appearancehttps://modernaesthetics.com/news/carotenoid-supplement-may-boost-skin-health-and-appearance/2473372/Daily supplementation with Lycomato may improve fine lines, wrinkles, pore appearance brightness/radiance, skin tone evenness, dark spot intensity, smoothness, and firmness after four weeks of use, according to a
- Revance Resubmits BLA for DaxibotulinumtoxinAhttps://modernaesthetics.com/news/revance-resubmits-bla-for-daxibotulinumtoxina/2473204/Revance Therapeutics, Inc. has resubmitted its Biologics License Application (BLA) to FDA for DaxibotulinumtoxinA for Injection for the treatment of moderate to severe glabellar lines. The submission is in response to the Complete Response Letter (CRL) issued by FDA in October 2021. The
- Nutrafol Launches Pro-Strength Boostershttps://modernaesthetics.com/news/nutrafol-launches-pro-strength-boosters/2473071/New professional-strength boosters from Nutrafol extend the popular nutraceutical line, providing physicians the opportunity to individualize recommendations for each patient’s specific hair health needs. Hairbiotic MD is a professional-strength
- Revance Update: FDA Defers Approval of DaxibotulinumtoxinA Due to COVID-19 Related Travel Restrictions Impacting Manufacturing Site Inspectionhttps://modernaesthetics.com/news/revance-update-fda-defers-approval-of-daxibotulinumtoxina-due-to-covid-19-related-travel-restrictions-impacting-manufacturing-site-inspection/2473027/The U.S. Food and Drug Administration (FDA) deferred a decision on the Biologics License Application (BLA) for Revance’s DaxibotulinumtoxinA for Injection, an investigational neuromodulator product for the treatment of moderate to severe glabellar lines. In a communication r
- SkinKick Kicks Off Ulta Partnershiphttps://modernaesthetics.com/news/skinkick-kicks-off-ulta-partnership/2473076/Through a new partnership with beauty retailer Ulta Beauty™, SkinKick® is available in stores nationwide this week. Dubbed the Naturally Smart® skincare line,
- Revance's DAXI Now One Step Closer to FDA Nodhttps://modernaesthetics.com/news/revances-daxi-now-one-step-closer-to-fda-nod/2472849/Revance Therapeutics, Inc. has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for DaxibotulinumtoxinA for Injection (DAXI) in the treatment of moderate to severe glabellar lines. Under